| Style | Citing Format |
|---|---|
| MLA | Shirvani G, et al.. "Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins." Journal of Labelled Compounds and Radiopharmaceuticals, vol. 59, no. 4, 2016, pp. 153-156. |
| APA | Shirvani G, Shockravi A, Amini M, Saemian N (2016). Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins. Journal of Labelled Compounds and Radiopharmaceuticals, 59(4), 153-156. |
| Chicago | Shirvani G, Shockravi A, Amini M, Saemian N. "Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins." Journal of Labelled Compounds and Radiopharmaceuticals 59, no. 4 (2016): 153-156. |
| Harvard | Shirvani G et al. (2016) 'Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins', Journal of Labelled Compounds and Radiopharmaceuticals, 59(4), pp. 153-156. |
| Vancouver | Shirvani G, Shockravi A, Amini M, Saemian N. Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins. Journal of Labelled Compounds and Radiopharmaceuticals. 2016;59(4):153-156. |
| BibTex | @article{ author = {Shirvani G and Shockravi A and Amini M and Saemian N}, title = {Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins}, journal = {Journal of Labelled Compounds and Radiopharmaceuticals}, volume = {59}, number = {4}, pages = {153-156}, year = {2016} } |
| RIS | TY - JOUR AU - Shirvani G AU - Shockravi A AU - Amini M AU - Saemian N TI - Synthesis of 2-(Methylsulfonyl)-5-(4-(Methylsulfonyl) Phenyl)-4-Phenyl-1H-[5-14C]Imidazole, a Selective Cox-2 Inhibitor, Via Asymmetrical Benzoins JO - Journal of Labelled Compounds and Radiopharmaceuticals VL - 59 IS - 4 SP - 153 EP - 156 PY - 2016 ER - |